69042
氯化锶 溶液
0.1 M
别名:
Additive Screening Solution 27/Kit-No 78374
登录 查看组织和合同定价。
选择尺寸
关于此项目
化学文摘社编号:
NACRES:
NA.32
PubChem Substance ID:
UNSPSC Code:
12352302
MDL number:
Form:
liquid
General description
Strontium chloride solution is an additive screening solution of Additive Screening Kit. Additive Screen kit is designed to allow rapid and convenient evaluation of additives and their ability to influence the crystallization of the sample. The Additive Kit provides a tool for refining crystallization conditions.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
存储类别
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Gang Liu et al.
Theriogenology, 113, 78-84 (2018-02-24)
The survival rate of vitrified-thawed ovarian tissues after autotransplantation still needs to be improved. Therefore finding an ideal cryoprectant to reduce the damage to ovaries that caused by vitrification will pave the way for application of ovary cryopreservation on clinics.
Seiichiro Ota et al.
Kaku igaku. The Japanese journal of nuclear medicine, 48(2), 101-107 (2011-07-09)
89Sr bremsstrahlung SPECT imaging has been evaluated for detecting the more detailed whole body 89Sr distribution. 89Sr bremsstrahlung whole body planar and merged SPECT images were acquired by using two detectors type SPECT system. Energy window A (100 keV +/-
D K Fomin et al.
Voprosy onkologii, 58(1), 116-118 (2012-05-29)
The study was designed to compare the effectivnes of 89Sr-chlorid injections by 50 Mbk fractions with standard 150 Mbk injection in patients with bone metastases. Fifty patients with bone metastases were included in the study, 25 of them received 89Sr-chloride
Hengchao Liu et al.
Oncology reports, 28(5), 1894-1902 (2012-08-28)
The aim of this study was to investigate the radiosensitizing effects of arsenic trioxide (As2O3) on MCF-7 human breast cancer cells irradiated with 89 strontium chloride (89SrCl2). The 50% inhibitory concentration (IC50) was calculated from results of an MTT assay.
Fan Yang et al.
Stem cells (Dayton, Ohio), 29(6), 981-991 (2011-05-13)
Strontium ranelate is a newly approved drug that can reduce the risk of vertebral fracture, which is attributed to its dual function in increasing the bone formation and decreasing the bone resorption. Strontium-containing hydroxyapatite was also demonstrated to stimulate the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持